Medico Remedies Limited (BOM:540937)

Market Cap	2.77B -40.2%
Revenue (ttm)	1.91B +26.4%
Net Income	115.99M +31.0%
EPS	1.40 +32.1%
Shares Out	82.98M
PE Ratio	23.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,076
Average Volume	7,215
Open	36.92
Previous Close	36.05
Day's Range	35.65 - 38.64
52-Week Range	34.00 - 62.00
Beta	0.09
RSI	28.92
Earnings Date	May 30, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 213
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540937

Financial Performance

In fiscal year 2025, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.